Cargando…
Outcome of Primary Mediastinal Large B Cell Lymphoma Treated with RCHOP
PURPOSE: Primary mediastinal large B-cell Lymphoma (PMLBCL) is a rare aggressive lymphoma with unique clinical, pathological, and molecular features. The optimal frontline therapy is subject of ongoing debate. Our study aims to evaluate the outcomes of PMLBCL treated with rituximab, cyclophosphamide...
Autores principales: | Halahleh, Khalid, Yaseen, Abeer, Muradi, Isra, Al-Ibraheem, Akram, Sultan, Iyad, Ma’koseh, Mohammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952517/ https://www.ncbi.nlm.nih.gov/pubmed/36846350 http://dx.doi.org/10.2147/JBM.S393180 |
Ejemplares similares
-
Classical Hodgkin Lymphoma on the Background of Castleman Disease: A Case Report
por: Ma'koseh, Mohammad, et al.
Publicado: (2023) -
Interim FDG-PET/CT for therapy monitoring and prognostication in Hodgkin’s Lymphoma
por: Al-Ibraheem, Akram, et al.
Publicado: (2022) -
The Application of the ThroLy Risk Assessment Model to Predict Venous
Thromboembolism in Patients with Diffuse Large B-Cell Lymphoma
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2021) -
The Impact of Graft CD3(+) T-Cell Dose on the Outcome of T-Cell Replete Human Leukocyte Antigen-Mismatched Allogeneic Hematopoietic Peripheral Blood Stem Cells Transplantation
por: Halahleh, Khalid, et al.
Publicado: (2023) -
Treatment of adult Burkitt lymphoma with the CALGB 1002 protocol: a single center experience in Jordan
por: Ma’koseh, Mohammad, et al.
Publicado: (2021)